Etiracetam

Suppliers

Names

[ CAS No. ]:
103765-01-1

[ Name ]:
Etiracetam

[Synonym ]:
1-Pyrrolidineacetamide, α-ethyl-2-oxo-
(2R)-2-(2-Oxo-1-pyrrolidinyl)butanimidic acid
1-Pyrrolidineethanimidic acid, α-ethyl-2-oxo-, (αR)-
Etiracetam, R-(+)-
(±)-a-Ethyl-2-oxo-1-pyrrolidineacetamide
(2R)-2-(2-oxopyrrolidin-1-yl)butanamide
T5NVTJ AY2&VZ
(R)-2-(2-oxopyrrolidin-1-yl)butanamide
Etiracetam
1-Pyrrolidineacetamide, α-ethyl-2-oxo-, (αR)-
2-(2-Oxo-1-pyrrolidinyl)butanamide
α-Ethyl-2-oxo-1-pyrrolidineacetamide
UNII:230447L0GL
C8H14N2O2
Torleva
乙拉西坦
2-(2-Oxopyrrolidin-1-yl)butyramide
ucb L060
(±)-α-Ethyl-2-oxo-1-pyrrolidineacetamide
Leviteracetam
(2R)-2-(2-Oxo-1-pyrrolidinyl)butanamide
2-(2-oxopyrrolidin-1-yl)butanamide
LEVITIRACETAM
Levetiracetam Impurity 4

Chemical & Physical Properties

[ Density]:
1.2±0.1 g/cm3

[ Boiling Point ]:
395.9±25.0 °C at 760 mmHg

[ Molecular Formula ]:
C8H14N2O2

[ Molecular Weight ]:
170.209

[ Flash Point ]:
193.2±23.2 °C

[ Exact Mass ]:
170.105530

[ PSA ]:
64.39000

[ LogP ]:
-0.67

[ Vapour Pressure ]:
0.0±0.9 mmHg at 25°C

[ Index of Refraction ]:
1.519

Articles

Inhibition of excitatory synaptic transmission in hippocampal neurons by levetiracetam involves Zn²⁺-dependent GABA type A receptor-mediated presynaptic modulation.

J. Pharmacol. Exp. Ther. 348(2) , 246-59, (2014)

Levetiracetam (LEV) is an antiepileptic drug with a unique but as yet not fully resolved mechanism of action. Therefore, by use of a simplified rat-isolated nerve-bouton preparation, we have investiga...

Efficacy and safety of pregabalin versus levetiracetam as adjunctive therapy in patients with partial seizures: a randomized, double-blind, noninferiority trial.

Epilepsia 55(7) , 1048-57, (2014)

To assess the comparative efficacy and safety of pregabalin and levetiracetam for the reduction of seizure frequency in patients with partial seizures.This was a randomized, double-blind, flexible-dos...

[Epilepsy in the elderly].

Tidsskr. Nor. Laegeforen. 133(5) , 528-31, (2013)

Diagnostic work-up and treatment of patients who have developed epilepsy after the age of 65 can both be difficult. Epilepsy is one of the most common neurological conditions in the elderly, and the i...


More Articles

Related Compounds

  • Etiracetam
  • Etiracetam-d3
  • Levetiracetam
  • 2-(3-Chlorothiophen-2-yl)-1,1-difluoropropan-2-amine
  • 1-cyclopentyl-N-methyl-1-(thiophen-2-yl)methanesulfonamide
  • 1-(2-chloro-5-nitrophenyl)-N-methylmethanesulfonamide
  • 6-bromo-N-methyl-3,4-dihydro-2H-1-benzopyran-4-sulfonamide
  • 1-(4-bromo-2-nitrophenyl)-N-methylmethanesulfonamide
  • 1-(1-benzyl-1H-pyrazol-4-yl)-N-methylmethanesulfonamide
  • 1,1-dicyclobutyl-N-methylmethanesulfonamide
  • 1-(2,5-dimethylthiophen-3-yl)-N-methylethane-1-sulfonamide
  • N-methyl-1-(5-nitrothiophen-3-yl)methanesulfonamide
  • 2-[1-(Aminomethyl)cyclopropyl]-3-methoxybutan-2-ol
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.